Taiwan · Delayed Price · Currency is TWD G&E Herbal Biotechnology Statistics
Total Valuation
TPEX:4911 has a market cap or net worth of TWD 2.29 billion. The enterprise value is 1.86 billion.
| Market Cap | 2.29B |
| Enterprise Value | 1.86B |
Important Dates
The next estimated earnings date is Friday, May 8, 2026.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | Jul 29, 2025 |
Share Statistics
TPEX:4911 has 63.72 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 63.72M |
| Shares Outstanding | 63.72M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 25.32% |
| Owned by Institutions (%) | n/a |
| Float | 47.59M |
Valuation Ratios
The trailing PE ratio is 16.47.
| PE Ratio | 16.47 |
| Forward PE | n/a |
| PS Ratio | 7.40 |
| PB Ratio | 2.46 |
| P/TBV Ratio | 2.88 |
| P/FCF Ratio | 34.16 |
| P/OCF Ratio | 32.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.41, with an EV/FCF ratio of 27.74.
| EV / Earnings | 13.35 |
| EV / Sales | 6.01 |
| EV / EBITDA | 11.41 |
| EV / EBIT | 12.20 |
| EV / FCF | 27.74 |
Financial Position
The company has a current ratio of 10.09, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.09 |
| Quick Ratio | 9.51 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 5,251.76 |
Financial Efficiency
Return on equity (ROE) is 15.80% and return on invested capital (ROIC) is 27.07%.
| Return on Equity (ROE) | 15.80% |
| Return on Assets (ROA) | 9.84% |
| Return on Invested Capital (ROIC) | 27.07% |
| Return on Capital Employed (ROCE) | 16.41% |
| Weighted Average Cost of Capital (WACC) | -0.78% |
| Revenue Per Employee | 7.93M |
| Profits Per Employee | 3.57M |
| Employee Count | 39 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.95 |
Taxes
In the past 12 months, TPEX:4911 has paid 19.20 million in taxes.
| Income Tax | 19.20M |
| Effective Tax Rate | 12.12% |
Stock Price Statistics
The stock price has decreased by -30.39% in the last 52 weeks. The beta is -0.91, so TPEX:4911's price volatility has been lower than the market average.
| Beta (5Y) | -0.91 |
| 52-Week Price Change | -30.39% |
| 50-Day Moving Average | 38.89 |
| 200-Day Moving Average | 46.49 |
| Relative Strength Index (RSI) | 44.67 |
| Average Volume (20 Days) | 48,065 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4911 had revenue of TWD 309.13 million and earned 139.20 million in profits. Earnings per share was 2.18.
| Revenue | 309.13M |
| Gross Profit | 263.22M |
| Operating Income | 152.30M |
| Pretax Income | 158.39M |
| Net Income | 139.20M |
| EBITDA | 162.91M |
| EBIT | 152.30M |
| Earnings Per Share (EPS) | 2.18 |
Balance Sheet
The company has 430.31 million in cash and 869,000 in debt, with a net cash position of 429.44 million or 6.74 per share.
| Cash & Cash Equivalents | 430.31M |
| Total Debt | 869,000 |
| Net Cash | 429.44M |
| Net Cash Per Share | 6.74 |
| Equity (Book Value) | 928.07M |
| Book Value Per Share | 14.45 |
| Working Capital | 427.64M |
Cash Flow
In the last 12 months, operating cash flow was 70.18 million and capital expenditures -3.20 million, giving a free cash flow of 66.98 million.
| Operating Cash Flow | 70.18M |
| Capital Expenditures | -3.20M |
| Depreciation & Amortization | 10.61M |
| Net Borrowing | -877,000 |
| Free Cash Flow | 66.98M |
| FCF Per Share | 1.05 |
Margins
Gross margin is 85.15%, with operating and profit margins of 49.27% and 45.03%.
| Gross Margin | 85.15% |
| Operating Margin | 49.27% |
| Pretax Margin | 51.24% |
| Profit Margin | 45.03% |
| EBITDA Margin | 52.70% |
| EBIT Margin | 49.27% |
| FCF Margin | 21.67% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 1.95%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 1.95% |
| Dividend Growth (YoY) | 43.24% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 32.08% |
| Buyback Yield | -0.07% |
| Shareholder Yield | 1.94% |
| Earnings Yield | 6.09% |
| FCF Yield | 2.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 29, 2025. It was a forward split with a ratio of 1.08.
| Last Split Date | Jul 29, 2025 |
| Split Type | Forward |
| Split Ratio | 1.08 |
Scores
TPEX:4911 has an Altman Z-Score of 41.23 and a Piotroski F-Score of 6.
| Altman Z-Score | 41.23 |
| Piotroski F-Score | 6 |